SenesTech Inc. Common Stock (SNES)
Stock · NASDAQ · Industrials
$0.6248as of 10/16/2026
Price chart
Active signals
SNES Signal Track Record
How signals performed across all stocks →What SNES's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 28 | -12.4% | 32% | October 2, 2026 |
| Bollinger Band Breakdown | 25 | -9.7% | 28% | September 8, 2026 |
| Bollinger Band Breakout | 17 | -15.3% | 29% | August 4, 2026 |
| 200-Day Moving Average TouchActive now | 3 | +2.8% | 67% | October 28, 2025 |
| Any 20-session window (baseline) | -13.5% | 29% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SNES
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first…
- Sector
- Industrials
- Industry
- Agricultural Chemicals
- Employees
- 23
- Website
- senestech.com/
Fundamentals
- 1-day range
- $0.55$0.6598
- Market cap
- $6.74M
- P/E (trailing)
- —
- P/E (forward)
- -0.14
- EPS (trailing)
- $-1.36
- Dividend yield
- —
- Beta
- 0.20
- Avg. volume
- 1.00M
- Dividend pay date
- February 5, 2020
How SenesTech Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 13, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
SenesTech Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SNESSenesTech Inc. Common Stock$0.647▼ 7.44%Market cap $6.74MP/E —$0.6101$4.19
- EVGNEvogene Ltd Ordinary Shares$0.39▼ 2.50%Market cap $9.08MP/E —$0.3521$1.49
- NXTSNexentis Technologies Inc. Common Stock$0.645▼ 5.43%Market cap $2.80MP/E —$0.6$32.9
- FRTTFort Technology Inc. Common Shares$0.54▼ 10.00%Market cap $14.75MP/E —$0.6003$4.09
- BIOXBioceres Crop Solutions Corp. Ordinary Shares$0.276▼ 6.12%Market cap $22.76MP/E —$0.28$2.19
- AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$1.06▼ 15.20%Market cap $88.01MP/E —$1.13$5.55
- CBUSCibus Inc. Class A Common Stock$1.32▲ 2.33%Market cap $142.74MP/E —$1.09$4.19
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SNES SenesTech Inc. Common Stock | $6.74M | — | $0.647 | ▼ 7.44% | $0.6101$4.19 |
| EVGN Evogene Ltd Ordinary Shares | $9.08M | — | $0.39 | ▼ 2.50% | $0.3521$1.49 |
| NXTS Nexentis Technologies Inc. Common Stock | $2.80M | — | $0.645 | ▼ 5.43% | $0.6$32.9 |
| FRTT Fort Technology Inc. Common Shares | $14.75M | — | $0.54 | ▼ 10.00% | $0.6003$4.09 |
| BIOX Bioceres Crop Solutions Corp. Ordinary Shares | $22.76M | — | $0.276 | ▼ 6.12% | $0.28$2.19 |
| AVD American Vanguard Corporation Common Stock ($0.10 Par Value) | $88.01M | — | $1.06 | ▼ 15.20% | $1.13$5.55 |
| CBUS Cibus Inc. Class A Common Stock | $142.74M | — | $1.32 | ▲ 2.33% | $1.09$4.19 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- SenesTech Reports Q34 Preliminary Revenue Of ~$1.1M, Up 55% YoYbenzinga · 10/15/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/2/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 9/29/2026
- SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused ConsumersYahoo · 9/23/2026
- SenesTech to Participate in the Lytham Partners Fall 2026 Investor ConferenceYahoo · 9/17/2026
Insider Activity
Insider Actions →- Edell Michael · September 28, 2026 · Buy2.0K @ $0.6444
- Edell Michael · September 14, 2026 · Buy1.0K @ $0.84
- Edell Michael · September 9, 2026 · Buy1.0K @ $0.89
- Edell Michael · August 14, 2026 · Buy1.0K @ $1.21
- GLENBROOK CAPITAL MANAGEMENT · August 7, 2026 · Buy6.5K @ $1.3
- GLENBROOK CAPITAL MANAGEMENT · August 6, 2026 · Buy15.0K @ $1.3
- GLENBROOK CAPITAL MANAGEMENT · July 20, 2026 · Buy35.0K @ $1.47
- Edell Michael · July 7, 2026 · Buy1.0K @ $1.43
- GLENBROOK CAPITAL MANAGEMENT · June 30, 2026 · Buy35.0K @ $1.51
- GLENBROOK CAPITAL MANAGEMENT · June 22, 2026 · Buy5.0K @ $1.66
- GLENBROOK CAPITAL MANAGEMENT · June 17, 2026 · Buy3.3K @ $1.61
- Matthew K. Szot · June 15, 2026 · Grant100.0K
- CHESTERMAN THOMAS C · June 15, 2026 · Grant75.0K
- Edell Michael · June 9, 2026 · Grant263.3K
- Edell Michael · June 8, 2026 · Buy1.0K @ $1.55
Institutional Ownership
March 31, 2026
- Total shares held
- 589.8K
- Total value held
- $963.0K
- Institutional holders
- 14
- Unknown218.5K
- Unknown114.0K
- Unknown63.1K
- Unknown42.9K
- Unknown26.3K
- Unknown21.1K
- Unknown20.9K
- Unknown19.1K
- Unknown16.7K
- Unknown16.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SNES Included in 12 Health Care Stocks Moving in Pre‑Market Session
SenesTech Inc. (SNES) was listed among 12 health‑care names that saw movement in Tuesday’s pre‑market session. The stock experienced a volume spike and is trading near its $1.59 support level, below its 52‑week range. Analysts have a target range of $3.50 to $10.00, with an average of $6.75. The move reflects short‑term interest rather than a fundamental shift.
SNES Included in 12 Health Care Stocks Moving in Pre‑Market Session. SenesTech Inc. (SNES) was listed among 12 health‑care names that saw movement in Tuesday’s pre‑market session. The stock experienced a volume spike and is trading near its $1.59 support level, below its 52‑week range. Analysts have a target range of $3.50 to $10.00, with an average of $6.75. The move reflects short‑term interest rather than a fundamental shift.